• 吴惠霞

    发布者⚀:信息发布员发布时间👍🏽:2017-04-24浏览次数🧔🏿‍♂️:5343


    1. 个人简介:

    吴惠霞,博士,教授,无机化学专业硕士生导师。现任无机化学硕士点负责人和无机化学教研室主任。

    教育经历⚧:

    2003.9-2006.6,博士💞,复旦大学

    1993.9-1996.6,硕士,华东师范大学

    1989.9-1993.7学士🤱🏽🚶‍♀️,华东师范大学

    工作经历🧑‍🎤:

    19967月至今,上海顺盈平台娱乐 教师

    其中👨🏿‍🦰,2009年至2011年,中国科顺盈平台上海硅酸盐研究所🧑🏻‍💼,博士后


    2. 主要研究方向:

    [1] 有机-无机纳米杂化材料#️⃣。

    [2] 纳米生物材料


    3. 代表性科研项目🧎‍♂️:

    [1] 碳纳米管表面纳米粒子修饰及其非线性光学性质研究,国家自然科学基金(面上项目),2010.12012.12

    [2] 多功能碳纳米管的制备及其在靶向超声/磁共振成像中的应用👂🏿,上海自然科学基金🙎,2013.72016.6

    [3]基于三元硫属化合物多功能纳米材料的构建及在双模式成像与近红外光热治疗中的应用,上海市教委科研创新重点项目,2014.12016.12


    4. 代表性论文:

    [1] Hao Zhang, Huixia Wu*, Jun Wang, Yan Yang, Dongmei Wu, Yingjian Zhang, Yang Zhang, Zhiguo Zhou, Shiping Yang*. Graphene oxide-BaGdF5 nanocomposites for multi-modal imaging and photothermal therapy. Biomaterials, 2015, 42, 66–77.

    [2] Huixia Wu*, Haili Shi, Hao Zhang, Xue Wang, Yan Yang, Chao Yu, Caiqin Hao, Jing Du, He Hu, Shiping Yang*. Prostate stem cell antigen antibody conjugated multiwalled carbon nanotubes for targeted ultrasound imaging and drug delivery. Biomaterials, 2014, 35, 5369–5380.

    [3] Huixia Wu, Gang Liu, Yeming Zhuang, Dongmei Wu, Haoqiang Zhang, Hong Yang, He Hu, Shiping Yang*. The behavior after intravenous injection in mice of multiwalled carbon nanotube/Fe3O4 hybrid MRI contrast agents. Biomaterials, 2011, 32, 4867-4876.

    [4] Huixia Wu, Shengjian Zhang, Jiamin Zhang, Gang Liu, Jianlin Shi*, Lingxia Zhang, Xiangzhi Cui, Meiling Ruan, Qianjun He, Wenbo Bu. A hollow core/magnetic and mesoporous double-shell nanostructure: in-situ decomposition/reduction synthesis, bio-imaging and drug delivery properties. Adv. Funct. Mater., 2011, 21, 1850–1862.

    [5] Xiaoqing Jia, Xiaojun Cai, Yu Chen, Shige Wang, Huixiong Xu, Kun Zhang, Ming Ma, Huixia Wu*, Jianlin Shi, and Hangrong Chen*. Perfluoropentane-encapsulated hollow mesoporous Prussian blue nanocubes for activated ultrasound imaging and photothermal therapy of cancer. ACS Appl. Mater. Interfaces, 2015, 7, 4579–4588.

    [6] Linlin Guo, Haili Shi, Huixia Wu*, Yixue Zhang, Xue Wan, Dongmei Wu, Lu An, Shiping Yang. Prostate cancer targeted multifunctionalized graphene oxide for magnetic resonance imaging and drug delivery. Carbon, 2016, 107, 87–99.

    [7] Huixia Wu*, Haili Shi, Yapei Wang, Xiaoqing Jia, Caizhi Tang, Jiamin Zhang, Shiping Yang*. Hyaluronic acid conjugated graphene oxide for targeted drug delivery. Carbon, 2014, 69, 379–389.

    [8] Huixia Wu*, Dandan Liu, Haoqiang Zhang, Chenyang Wei, Bo Zeng, Jianlin Shi, Shiping Yang. Solvothermal synthesis and optical limiting properties of carbon nanotube-based hybrids containing ternary chalcogenides. Carbon, 2012, 50, 4847–4855.

    [9] Huixia Wu, Gang Liu, Xue Wang, Jiamin Zhang, Yu Chen, Jianlin Shi, Hong Yang, He Hu, Shiping Yang*. Solvothermal synthesis of cobalt ferrite nanoparticles loaded on multi-walled carbon nanotubes for magnetic resonance imaging and drug delivery. Acta Biomater., 2011, 7, 3496–3504.

    [10] Yixue Zhang, Hao Zhang, Yanke Wang, Huixia Wu*, Bo Zeng, Yingjian Zhang, Qiwei Tian, Shiping Yang*. Hydrophilic graphene oxide/bismuth selenide nanocomposites for CT imaging, photoacoustic imaging, and photothermal therapy. J. Mater. Chem. B, 2017, 5, 1846–1855.


    5. 获奖情况:

    [1] 上海市研究生优秀成果(学位论文)指导教师🌶,2016年〰️。

    [2] 上海市研究生优秀成果(学位论文)指导教师,2013年。

    [3] 上海市级教学成果奖二等奖(排名第三),2013年🤹🏼‍♂️。


    6. 代表性授权专利🎅🏻:

    [1]发明人:吴惠霞👩‍🚒🎀,张浩,侍海丽,王俊,杨仕平,专利名称:一种氧化石墨烯/BaGdF5/PEG多功能材料及其制备方法和应用,专利号⚔️:201310347872.0

    [2] 发明人:吴惠霞,杨艳🚍,张皓辉,杨仕平🪣🌜,专利名称🌙:一种Cu3BiS3三元硫属纳米材料及其制备方法,专利号🤹🏼:201310529991.8

    [3] 发明人𓀀:吴惠霞,侍海丽👬,王雪🎹,杨仕平,专利名称:氧化石墨烯/PAMAM/DTPA-Gd/PSCA抗体多功能材料及其制备方法和应用🧝,专利号:201210138084.6

    [4] 发明人🌌:吴惠霞,王雪🙎‍♀️🍄‍🟫,侍海丽,杨仕平👨‍🦼‍➡️,专利名称:前列腺癌靶向多功能碳纳米管/聚乙烯亚胺药物传输载体及其制备方法和应用,专利号:201210081507.5

    [5] 发明人👯‍♂️🤛:吴惠霞,汤才志🍜,杨昕仪🧚🏿‍♀️🚃,于超,杨仕平🏄🏿,专利名称🥏☂️:一种光敏剂修饰的核壳结构磁性纳米复合材料及其制备方法和应用🎪,专利号🧑🏿‍🔬:201310368539.8

    Email: wuhuixia@shnu.edu.cn



    更新于201711

    顺盈平台专业提供:顺盈平台⚰️👸🏿、等服务,提供最新官网平台、地址、注册、登陆、登录、入口、全站、网站、网页、网址、娱乐、手机版、app、下载、欧洲杯、欧冠、nba、世界杯、英超等,界面美观优质完美,安全稳定,服务一流,顺盈平台欢迎您。 顺盈平台官网xml地图
    顺盈平台 顺盈平台 顺盈平台 顺盈平台 顺盈平台 顺盈平台 顺盈平台 顺盈平台 顺盈平台 顺盈平台